New Breast Scanning Technology Might Beat Standard Mammography
TUESDAY, March 14, 2023 (HealthDay News) — Newer scanning technology may spot more breast cancers and lower the rate of dreaded false positives, a large, new study shows.Now available in a growing number of health care facilities, tomosynthesis uses …
Learn MoreFDA Expands Indication for Use of Abemaciclib With Early, High-Risk Breast Cancer
FRIDAY, March 10, 2023 (HealthDay News) — Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor r…
Learn MoreOlder Women Still at Risk for Cancer With BRCA1/2 Mutations
THURSDAY, March 9, 2023 (HealthDay News) — The risk for cancer, including breast and ovarian cancer, remains high for women older than 50 years with genetic BRCA1 or BRCA2 mutations, according to a study published in the March 15 issue of Cancer.Kell…
Learn MoreMammogram Centers Must Notify Patients of Breast Density, FDA Says
THURSDAY, March 9, 2023 (HealthDay News) — New U.S. federal regulations will require mammography facilities to tell women if they have dense breasts, a description of how the tissue looks on the X-ray.It can be more difficult to detect cancer in dens…
Learn MoreGeographical, Racial/Ethnic Differences Seen for Triple-Negative Breast Cancer
WEDNESDAY, March 8, 2023 (HealthDay News) — There are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online March 2 in JAMA Oncology…
Learn MoreAnatomic Stage, Receptor Status Influence Timing of Breast Cancer Recurrence
MONDAY, March 6, 2023 (HealthDay News) — Anatomic stage and receptor status influence the timing of recurrence for patients with local-regional breast cancer, according to a study published online March 6 in Cancer.Heather B. Neuman, M.D., from the U…
Learn MoreBreast Cancer Risk Estimate Models Vary Substantially at Individual Level
FRIDAY, March 3, 2023 (HealthDay News) — Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, according to a study published online Feb. 7 in the Journal of General Internal Medicine.J…
Learn MoreBreast, Cervical, Prostate Cancer Screening Still Lower Than Before Pandemic
FRIDAY, March 3, 2023 (HealthDay News) — Among age-eligible adults in the United States, the prevalence of past-year screening for breast, cervical, and prostate cancer continued to be lower in 2021 than prepandemic levels, according to a study publi…
Learn MoreSurvival Rate Lower for Surgery Nine Weeks or More After Breast Cancer Diagnosis
THURSDAY, March 2, 2023 (HealthDay News) — Time from breast cancer diagnosis to surgery of nine weeks or longer is associated with worse overall survival, according to a study published online March 1 in JAMA Surgery.Alyssa A. Wiener, M.D., from the …
Learn More